The EVOLVE China Clinical Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 412 participants.
Also called NCT01966159
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 412 participants
- Sponsor
- Registry
-
NCT01966159
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01966159. Randomized; single masking; primary purpose treatment. Start 2013-10 (registry gives no type); primary completion 2014-07 (actual). Results posted on 2016-02-18.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The EVOLVE China Clinical Trial
- Acronym
- EVOLVE-CHINA
- Condition
- Coronary Artery Disease
- Intervention (Device)
- SYNERGY Investigational Device
- Intervention (Device)
- PE Plus Investigational Device
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct01966159- Content hash
0f1585d887009815da7ce600750fe9c06f1211cdae4425f9538cc41ead37ce6b